(2026). A TGFB2/TNF-induced in vitro model of proliferative vitreoretinopathy (PVR) using ARPE-19 cells confirms nicotinamide as an inhibitor of EMT and VEGFA secretion. PLOS ONE.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"A TGFB2/TNF-induced in Vitro Model of Proliferative Vitreoretinopathy (PVR) Using ARPE-19 Cells Confirms Nicotinamide as an Inhibitor of EMT and VEGFA Secretion."
PLOS ONE 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"A TGFB2/TNF-induced in Vitro Model of Proliferative Vitreoretinopathy (PVR) Using ARPE-19 Cells Confirms Nicotinamide as an Inhibitor of EMT and VEGFA Secretion."
PLOS ONE, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.